M.S. MANIFEST LIMITED

Company number 13458978 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

M.S. MANIFEST LIMITED - Analysis Report

Company Number: 13458978

Analysis Date: 2025-07-20 17:39 UTC

Financial Health Assessment for M.S. MANIFEST LIMITED


1. Financial Health Score: C

  • Explanation: The company shows signs of financial stress with a negative working capital and a substantial drop in cash reserves over the last year. While the net assets remain positive and the company holds significant fixed asset investments, the current liquidity position is weak, indicating potential short-term cash flow challenges. This warrants a cautious outlook with attention to improving liquidity and operational cash flow.

2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Cash & Cash Equivalents 8,501 56,292 Sharp decline indicating tightening liquidity "pulse".
Current Liabilities 31,703 15,892 Doubled current obligations, increasing short-term pressure.
Net Current Assets (23,202) 40,400 Negative working capital "symptom of distress" in short-term funds.
Fixed Asset Investments 150,001 150,001 Stable long-term asset base, "heart of company’s value".
Shareholders’ Funds 126,799 190,401 Decline shows erosion of equity, but still positive "vital organ".
  • Working Capital (Current Assets - Current Liabilities): Negative in 2024 indicates the company may struggle to meet short-term debts from current assets.
  • Cash Position: The cash reserve has dropped significantly from £56k to £8.5k, signaling reduced liquidity cushion.
  • Shareholders’ Funds: The equity base has decreased, reflecting accumulated losses or distributions, but remains positive.

3. Diagnosis

  • The "patient" (company) is experiencing liquidity strain evidenced by a declining cash balance and negative working capital. This is a "symptom" of cash flow issues or increased short-term debt.
  • The company's fixed asset investments remain stable, suggesting long-term assets have not been impaired or disposed of.
  • The drop in shareholders' funds signals that profitability or retained earnings have decreased, which could be due to operational losses or distributions.
  • The company’s status as a holding company (SIC 64209) means revenue generation depends heavily on subsidiary or investment performance, so short-term liquidity issues may stem from delayed dividends or investment income.
  • The company employs a small team (4 people), which aligns with a small company profile, but this also means operational flexibility may be limited.
  • No audit was required, so while the numbers are unaudited, the directors acknowledge compliance with accounting standards.
  • Overall, the company shows "vital signs" of financial stress but is not yet in critical condition ("no immediate insolvency signs")—though close monitoring is required.

4. Recommendations

  • Improve Cash Flow Management: Focus on accelerating receivables, deferring payables where possible, and reviewing operating expenses to rebuild healthy cash reserves.
  • Short-Term Financing: Consider arranging a short-term credit facility or working capital loan to bridge immediate liquidity gaps and avoid payment defaults.
  • Operational Review: Since the company is a holding entity, reassess the performance and dividend policies of subsidiaries to ensure regular cash inflows.
  • Cost Control: Evaluate overheads and non-essential expenditures to conserve cash until the liquidity position stabilizes.
  • Equity Injection: If feasible, a capital injection from shareholders or new investors could strengthen the equity base and support liquidity.
  • Regular Monitoring: Establish monthly financial "check-ups" focusing on cash flow forecasts and working capital trends to detect early signs of distress and act promptly.
  • Strategic Planning: Develop a medium-term plan to restore profitability and equity levels, possibly through restructuring or asset optimisation.

Medical Analogy Summary

M.S. MANIFEST LIMITED exhibits "symptoms of financial distress," particularly a weakening "heartbeat" in liquidity and working capital. While the "core organs" (fixed assets, equity) remain intact, the company's "circulatory system" (cash flow and short-term financial health) needs immediate attention to prevent further deterioration. With timely intervention and careful management, the company can regain its financial "vitality" and sustain operations healthily.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.